Therapy to Prevent Sexual Pain in Breast Cancer Survivors

Completed · Phase 3

Conditions studied: Vulvodynia, Dyspareunia, Breast Cancer, Menopause

In brief

The purpose of this protocol is to determine whether pain with sexual intercourse can be reduced in menopausal, breast cancer survivors and to evaluate the effectiveness of a non-hormonal therapy (Lidocaine Liquid) vs. a placebo liquid in reducing pain. The investigators hypothesize that the pain arises in the vulvar vestibule. The investigators predict that the localized use of lidocaine will be more efficacious than use of placebo liquid.

Key facts

Study ID

NCT01539317

Run by

OHSU Knight Cancer Institute

People needed

50

Starts

2011-12-01

Expected to finish

2013-11-01

Last updated by the study team

2017-04-14

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.